title: Anti-endotoxin vaccines: back to the future.
abstract: Gram-negative bacterial (GNB) infections are a leading cause of serious infections both in hospitals and the community. The mortality remains high despite potent antimicrobials and modern supportive care. In the last decade invasive GNB have become increasingly resistant to commonly used antibiotics, and attempts to intervene with novel biological therapies have been unsuccessful. Earlier studies with antibodies directed against a highly conserved core region in the GNB lipopolysaccharide (LPS, or endotoxin) suggested that this approach may have therapeutic benefit, and led to the development of a subunit vaccine that has progressed to phase 1 clinical testing. Since only a few serogroups of GNB cause bacteremia, O-specific vaccines had been developed, but these were not deployed because of the availability of other therapeutic options at the time. Given the likelihood that new antibiotics will not be soon available, the development of vaccines and antibodies directed against endotoxin, both O and core antigens, deserves a "second look".
authors: Center for Vaccine Development; University of Maryland School of Medicine; Baltimore, MD USA.
authors: Alan S
authors: AS
authors: Cross
mesh_terms: D001428:Bacterial Vaccines / Q000276:immunology* / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000276:immunology* / Q000472:pathogenicity; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology*; D018805:Sepsis / Q000188:drug therapy* / Q000517:prevention & control; D014611:Vaccination
chemical_list: D001428:Bacterial Vaccines; D008070:Lipopolysaccharides; C485022:lipopolysaccharide, E coli J5
keywords: antibody; clinical trial; core glycolipid; gram-negative bacteria; immunoglobulin; lipopolysaccharide; sepsis; vaccine
references: N Engl J Med. 1959 Oct 1;261:677-83
references: 14438354
references: J Infect Dis. 1988 Aug;158(2):291-300
references: 3042871
references: J Clin Invest. 1987 Jul;80(1):51-6
references: 3110215
references: Lancet. 1985 Jul 13;2(8446):59-63
references: 2861523
references: JAMA. 2001 Oct 17;286(15):1869-78
references: 11597289
references: Clin Microbiol Infect. 2012 Oct;18 Suppl 5:109-16
references: 22882709
references: Am J Med Sci. 1970 Feb;259(2):114-9
references: 4905231
references: AMA Arch Intern Med. 1951 Oct;88(4):467-88
references: 14867954
references: N Engl J Med. 1996 Jun 27;334(26):1697-702
references: 8637514
references: J Leukoc Biol. 2008 Mar;83(3):483-8
references: 18070981
references: JAMA. 2010 Oct 27;304(16):1787-94
references: 20978258
references: N Engl J Med. 2009 Jan 29;360(5):439-43
references: 19179312
references: J Immunol. 1972 Mar;108(3):601-10
references: 4622185
references: Vaccine. 1994 Nov;12(14):1288-94
references: 7856293
references: N Engl J Med. 1991 Nov 21;325(21):1453-60
references: 1944423
references: J Infect Dis. 1991 May;163(5):1055-61
references: 1902245
references: N Engl J Med. 1982 Nov 11;307(20):1225-30
references: 6752708
references: Eur J Cancer. 1979;15 Suppl:71-6
references: 397063
references: MMWR Morb Mortal Wkly Rep. 2013 Mar 8;62(9):165-70
references: 23466435
references: J Infect Dis. 1996 Sep;174(3):537-43
references: 8769611
references: Infect Immun. 2000 Nov;68(11):6202-8
references: 11035726
references: J Infect Dis. 2005 Dec 15;192(12):2074-80
references: 16288370
references: Infect Immun. 1993 Sep;61(9):3863-72
references: 8359907
references: J Endotoxin Res. 2002;8(1):39-46
references: 11981444
references: JAMA. 2010 Jun 9;303(22):2253-9
references: 20530778
references: Vaccine. 1995 Apr;13(5):449-53
references: 7639013
references: N Engl J Med. 2001 Mar 8;344(10):699-709
references: 11236773
references: JAMA. 2010 Oct 27;304(16):1833-4
references: 20978262
references: J Infect Dis. 1988 Aug;158(2):312-9
references: 3136210
references: Annu Rev Microbiol. 1967;21:443-66
references: 4860265
references: JAMA. 2013 Apr 17;309(15):1573-4
references: 23592085
references: JAMA. 1995 Mar 22-29;273(12):934-41
references: 7884952
references: N Engl J Med. 2013 Jan 24;368(4):299-302
references: 23343059
references: J Clin Invest. 1973 Dec;52(12):3236-8
references: 4584346
references: Scand J Infect Dis. 1989;21(6):697-708
references: 2617211
references: Infect Control Hosp Epidemiol. 2013 Mar;34(3):259-68
references: 23388360
references: FEMS Immunol Med Microbiol. 1996 Nov;16(1):21-30
references: 8954349
references: J Infect Dis. 1992 Apr;165(4):695-701
references: 1552198
references: N Engl J Med. 1992 Jul 23;327(4):234-40
references: 1614464
references: J Infect Dis. 1994 Sep;170(3):622-9
references: 8077720
references: JAMA. 1994 Jun 15;271(23):1836-43
references: 8196140
references: N Engl J Med. 1991 Feb 14;324(7):429-36
references: 1988827
references: J Am Med Assoc. 1959 Aug 29;170:2188-97
references: 13822924
references: J Clin Invest. 1983 Dec;72(6):1874-81
references: 6358257
references: Antimicrob Agents Chemother. 1998 Mar;42(3):583-8
references: 9517936
references: J Infect Dis. 1983 Jan;147(1):57-67
references: 6185599
references: Clin Infect Dis. 1996 Jul;23(1):179-81
references: 8816151
references: Semin Arthritis Rheum. 2012 Dec;42(3):223-33
references: 22748510
references: J Infect Dis. 1994 Oct;170(4):834-40
references: 7523536
references: J Biol Chem. 2003 Jul 11;278(28):25618-27
references: 12716894
references: JAMA. 1991 Aug 28;266(8):1097-102
references: 1865542
references: J Immunol. 1963 Feb;90:297-311
references: 14015019
references: J Infect Dis. 1989 Jun;159(6):1073-82
references: 2723454
references: JAMA. 1995 Jul 12;274(2):172-7
references: 7596007
references: J Clin Invest. 1960 Jan;39:82-8
references: 14437724
references: FEMS Immunol Med Microbiol. 2003 Jun 10;37(1):59-67
references: 12770761
references: Lancet. 1984 May 5;1(8384):981-3
references: 6143965
references: Lancet. 2000 Sep 16;356(9234):961-7
references: 11041396
references: Ann Surg. 1993 Mar;217(3):300-6
references: 8452409
references: JAMA. 2010 Oct 27;304(16):1856
references: 20978264
references: JAMA. 1997 Apr 2;277(13):1058-63
references: 9091694
references: Crit Care Med. 1991 Sep;19(9):1104-13
references: 1884609
references: Circ Shock. 1987;23(3):157-64
references: 3427771
references: Vaccine. 2004 Feb 17;22(7):818-21
references: 15040933
references: J Infect Dis. 1996 May;173(5):1157-63
references: 8627067
references: J Infect Dis. 1989 Aug;160(2):225-36
references: 2474616
references: Infect Immun. 1979 Mar;23(3):758-63
references: 378836
references: J Infect Dis. 2001 Apr 1;183(7):1079-86
references: 11237833
references: N Engl J Med. 2010 Dec 16;363(25):2377-9
references: 21158655
references: Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20877-82
references: 23184990
references: Ann N Y Acad Sci. 1966 Jun 30;133(2):746-62
references: 4164249
references: J Exp Med. 1909 Mar 1;11(2):241-56
references: 19867246